TR201716062A2 - Bi̇r eksozomal terapöti̇k taşiyici üreti̇m yöntemi̇ ve bu yönteme uygun bi̇r şeki̇lde elde edi̇len bi̇r eksozomal terapöti̇k taşiyici - Google Patents

Bi̇r eksozomal terapöti̇k taşiyici üreti̇m yöntemi̇ ve bu yönteme uygun bi̇r şeki̇lde elde edi̇len bi̇r eksozomal terapöti̇k taşiyici Download PDF

Info

Publication number
TR201716062A2
TR201716062A2 TR2017/16062A TR201716062A TR201716062A2 TR 201716062 A2 TR201716062 A2 TR 201716062A2 TR 2017/16062 A TR2017/16062 A TR 2017/16062A TR 201716062 A TR201716062 A TR 201716062A TR 201716062 A2 TR201716062 A2 TR 201716062A2
Authority
TR
Turkey
Prior art keywords
exosomal
therapeutic carrier
manufacturing
therapeutic
obtained suitable
Prior art date
Application number
TR2017/16062A
Other languages
English (en)
Inventor
Teki̇n Şaban
Erçelen Ceylan Şebnem
Original Assignee
Tuerkiye Bilimsel Ve Teknolojik Arastirma Kurumu Tuebitak
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tuerkiye Bilimsel Ve Teknolojik Arastirma Kurumu Tuebitak filed Critical Tuerkiye Bilimsel Ve Teknolojik Arastirma Kurumu Tuebitak
Priority to TR2017/16062A priority Critical patent/TR201716062A2/tr
Priority to PCT/IB2018/058077 priority patent/WO2019077534A1/en
Publication of TR201716062A2 publication Critical patent/TR201716062A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Bu buluş, kişiye özgü, hedeflendirilmiş ve düşük toksisiteye sahip olan eksozomal terapötik taşıyıcısı üretim yöntemi ve bu yönteme uygun olarak üretilen bir eksozomal terapötik taşıyıcı ile ilgilidir.
TR2017/16062A 2017-10-18 2017-10-18 Bi̇r eksozomal terapöti̇k taşiyici üreti̇m yöntemi̇ ve bu yönteme uygun bi̇r şeki̇lde elde edi̇len bi̇r eksozomal terapöti̇k taşiyici TR201716062A2 (tr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2017/16062A TR201716062A2 (tr) 2017-10-18 2017-10-18 Bi̇r eksozomal terapöti̇k taşiyici üreti̇m yöntemi̇ ve bu yönteme uygun bi̇r şeki̇lde elde edi̇len bi̇r eksozomal terapöti̇k taşiyici
PCT/IB2018/058077 WO2019077534A1 (en) 2017-10-18 2018-10-18 METHOD FOR PRODUCING EXOSOMAL THERAPEUTIC CARRIER AND EXOSOMAL THERAPEUTIC CARRIER PROPERLY OBTAINED USING THE SAME

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2017/16062A TR201716062A2 (tr) 2017-10-18 2017-10-18 Bi̇r eksozomal terapöti̇k taşiyici üreti̇m yöntemi̇ ve bu yönteme uygun bi̇r şeki̇lde elde edi̇len bi̇r eksozomal terapöti̇k taşiyici

Publications (1)

Publication Number Publication Date
TR201716062A2 true TR201716062A2 (tr) 2019-05-21

Family

ID=64607039

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2017/16062A TR201716062A2 (tr) 2017-10-18 2017-10-18 Bi̇r eksozomal terapöti̇k taşiyici üreti̇m yöntemi̇ ve bu yönteme uygun bi̇r şeki̇lde elde edi̇len bi̇r eksozomal terapöti̇k taşiyici

Country Status (2)

Country Link
TR (1) TR201716062A2 (tr)
WO (1) WO2019077534A1 (tr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201900007785A1 (it) * 2019-05-31 2020-12-01 Univ Degli Studi Milano Vescicole extracellulari per veicolare farmaci terapeutici o diagnostici
TR202006914A1 (tr) * 2020-05-04 2021-11-22 Univ Yeditepe İmmunoprofi̇lakti̇k ve i̇mmunoterapöti̇k olarak ekstraselüler vezi̇külleri̇ni̇n lei̇shmani̇asi̇s hastaliği i̇çi̇n kullanimi

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2788780B1 (fr) * 1999-01-27 2001-03-30 Ap Cells Inc Procede de preparation de vesicules membranaires
WO2004000229A2 (en) 2002-06-24 2003-12-31 Research Development Foundation Treatment of human multiple myeloma by curcumin
WO2011097480A1 (en) * 2010-02-05 2011-08-11 University Of Louisville Research Foundation, Inc. Exosomal compositions and methods for the treatment of disease
CN102349998A (zh) 2011-10-20 2012-02-15 天津大学 以外泌体为基础的疏水性抗癌药物制剂
US20130273544A1 (en) * 2012-04-17 2013-10-17 Life Technologies Corporation Methods and compositions for exosome isolation
US9943482B2 (en) * 2013-02-26 2018-04-17 University Of Louisville Research Foundation, Inc. Milk-derived microvesicle compositions and related methods
CA2960164A1 (en) * 2014-09-05 2016-03-10 Exerkine Corporation Methods of producing and using exersomes and bioengineered exersomes
EP3307890A1 (en) * 2015-06-10 2018-04-18 Board of Regents, The University of Texas System Use of exosomes for the treatment of disease
WO2017054086A1 (en) * 2015-10-01 2017-04-06 Exerkine Corporation Treatment of genetic myopathies using bioengineered exosomes

Also Published As

Publication number Publication date
WO2019077534A1 (en) 2019-04-25

Similar Documents

Publication Publication Date Title
CY1123920T1 (el) Αντιγριπικο πολυκυκλικο παραγωγο πυριδονης και προφαρμακο αυτου
CL2019002824A1 (es) Anticuerpos anti-lag3.
CL2020000594S1 (es) Estuche de auriculares.
CL2019002612A1 (es) Compuestos macrocíclicos como inhibidores de la quinasa ros1.
BR112016028045A2 (pt) Biopolímeros modificados, e seus métodos de produção
MX2017014809A (es) Amidas heterociclicas como inhibidores de cinasa.
EA202090720A1 (ru) ПРОИЗВОДНЫЕ GalNAc
JOP20190194B1 (ar) مركبات نيوكليوتيدات ثنائية حلقية لعلاج السرطان
MX382901B (es) Composiciones de angiotensinogeno (agt) arni y métodos de uso de las mismas.
MX373365B (es) Derivados de aminopiridina como inhibidores de cinasas de la familia de tyro3, axl y mer (tam).
CU20180001A7 (es) Derivados de oxopiridina sustituidos y procesos para su preparación
UY34824A (es) Nucleósidos de espirooxetano de uracilo
MX376083B (es) Formas de dosificacion solidas de palbociclib.
EA202092987A3 (ru) Липид, содержащий докозапентаеновую кислоту
MY205583A (en) Acid-alpha glucosidase variants and uses thereof
UY36737A (es) 3-amino-1,5,6,7-tetrahidro-4h-indol-4-onas
EA201591931A1 (ru) Композиции оксабициклогептанов и оксабициклогептенов
EA201792612A1 (ru) 6-аминохинолин-3-карбонитрилы в качестве модуляторов cot
CY1120759T1 (el) Παρασκευη διγλυκοζιτη (s,s)-σεκοϊσολαρικιρεσινολης και διγλυκοζιτη (r,r)-σεκοϊσολαρικιρεσινολης
EA201600026A1 (ru) Бактериальная гиалуронидаза и способ ее производства
UY36500A (es) Composiciones del inhibidor de la nitrificación y métodos de preparación de las mismas
MX2018007083A (es) Sintesis diaestereoselectiva de derivados de fosfato y del profarmaco de gemcitabina nuc-1031.
EA201792372A1 (ru) Композиции и способы для активного наблюдения за раком предстательной железы
CU24428B1 (es) Derivados de quinolizinona como inhibidores de pi3k
CL2016001488A1 (es) Quinazolin-thf-aminas como inhibidores de pde1